Epax AS continues expansion into the pharmaceutical omega-3 segment with study
on AKR963 successfully achieving phase 3 study efficacy endpoints.

Read Press Release

The Omega-3 lipids corporation previously formed by Trygg Pharma and former EPAX AS will be named EPAX AS. Former EPAX AS will become Epax Norway AS, a fully owned subsidiary and the key operating company of the Epax group.

Read press release

AALESUND, Norway (Nov. 29, 2010) — Baldur Hjaltason has been named the new chairman of the Global Organization for EPA and DHA Omega-3 (GOED) board of directors.

Read press release

AALESUND, Norway (Oct. 18, 2010) — EPAX AS confirmed today that its DHA-rich 1050 TG formula is currently being studied for its potential effect on metabolic syndrome and its associated conditions.

Recognition by Banner Pharmacaps, Inc. marks the third year in a row

EPAX has received the honor

Read press release

Epax AS continues expansion into the pharmaceutical omega-3 segment with study
on AKR963 successfully achieving phase 3 study efficacy endpoints.

Read Press Release

The Omega-3 lipids corporation previously formed by Trygg Pharma and former EPAX AS will be named EPAX AS. Former EPAX AS will become Epax Norway AS, a fully owned subsidiary and the key operating company of the Epax group.

Read press release

EPAX AS was recognized for on-time deliveries and high quality standards.

Read press release